MedTrace Logo

Growth Hormone Treatment of Women With Turner Syndrome

NCT00420654 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2011-11-08

No results posted yet for this study

Summary

Growth hormone treatment is used in girls with Turner syndrome to increase final height. The aim of this study is to evaluate the effect of growth hormone treatment on body composition and heart function in adult women with Turner syndrome. The hypothesis is that the fat mass will decrease and lean body mass will increase. There is only very limited documentation of the effect on the heart in this study population.

Conditions

  • Turner Syndrome

Interventions

DRUG

Growth Hormone

1.25 mg, 6 months

DRUG

Placebo

Equivalent to 1.25 mg, 6 months

OTHER

Healthy controls

Healthy controls

Sponsors & Collaborators

  • Britta E. Hjerrild

    lead OTHER

Principal Investigators

  • Jens S. Christiansen, prof. dr.med · University of Aarhus

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2011-09-30
Completion
2011-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00420654 on ClinicalTrials.gov